azithromycin NDC 70518-4367

NDC codes

FDA NDC Directory

Product NDC (as listed)70518-4367Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70518-4367Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
70518-4367-0	70518436700	30 TABLET, FILM COATED in 1 BLISTER PACK (70518-4367-0)Marketed from Jun 20, 2025
70518-4367-1	70518436701	2 POUCH in 1 BOX (70518-4367-1) / 1 TABLET, FILM COATED in 1 POUCH (70518-4367-2)Marketed from Jun 25, 2025
70518-4367-3	70518436703	2 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70518-4367-3)Marketed from Sep 26, 2025
70518-4367-4	70518436704	5 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (70518-4367-4)Marketed from Sep 1, 2026

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): azithromycin
Generic name (nonproprietary): azithromycin
Active ingredients: Azithromycin dihydrate — 500 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: REMEDYREPACK INC.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 065399
Marketing start: Jun 20, 2025
Listing expires: Dec 31, 2027
Other FDA classes: Macrolides (Chemical structure)
Identifiers: Product ID 70518-4367_5a7f288b-4e9c-15e9-e063-6294a90a949bSPL ID 5a7f288b-4e9c-15e9-e063-6294a90a949bSPL set ID bf061799-cdef-40f8-b1ce-bc5eb609f8c3RxCUI 248656UNII 5FD1131I7S
Pharmacologic class: Macrolide Antimicrobial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470518436700 followed by a unit qualifier and the quantity

Package 70518-4367-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 2, 2026.

Indications (excerpt from the label)

Azithromycin tablets are a macrolide antibacterial drug indicated for mild to moderate infections caused by designated, susceptible bacteria: Acute bacterial exacerbations of chronic bronchitis in adults ( 1.1 ) Acute bacterial sinusitis in adults ( 1.1 ) Uncomplicated skin and skin structure infections in adults ( 1.1 ) Urethritis and cervicitis in adults ( 1.1 ) Genital ulcer disease in men ( 1.1 ) Acute otitis media in pediatric patients (6 months of age and older) ( 1.2 ) Community-acquired pneumonia in adults and pediatric patients (6 months of age and older) ( 1.1 , 1.2 ) Pharyngitis/tonsillitis in adults and pediatric patients (2 years of age and older) ( 1.1 , 1.2 ) Limitation of Use…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 065399

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 065399
Product	Strength	Form · route	Labeler	Product NDC
azithromycin	Azithromycin dihydrate 500 mg/1	Tablet, Film coatedOral	Major Pharmaceuticals	0904-7351
azithromycin	Azithromycin dihydrate 500 mg/1	Tablet, Film coatedOral	Lupin Pharmaceuticals, Inc.	68180-862
Azithromycin	Azithromycin dihydrate 500 mg/1	Tablet, Film coatedOral	American Health Packaging	60687-753
azithromycin dihydrate	Azithromycin dihydrate 500 mg/1	TabletOral	Advanced Rx of Tennessee, LLC	80425-0412